---
figid: PMC4689482__OR-35-02-0607-g01
figlink: /pmc/articles/PMC4689482/figure/f2-or-35-02-0607/
number: F2
caption: Effects of ARID1A mutation and anticancer agents on the PI3K/AKT pathway.
  ARID1A mutations frequently co-occur with mutations of PTEN and PIK3CA. PTEN mutation
  inactivates PTEN and PIK3CA mutation activates PI3K, which lead to stimulation of
  cell growth, proliferation and survival. Temsirolimus inhibits the PI3K/AKT/mTOR
  signaling pathway by binding to the mTORC1 complex (). Sorafenib is a multikinase
  inhibitor that targets the mitogen-activated protein kinase (MAPK) pathway, and
  also inhibits vascular endothelial growth factor receptor (VEGFR) and platelet-derived
  growth factor receptor (PDGFR).
pmcid: PMC4689482
papertitle: ARID1A gene mutation in ovarian and endometrial cancers (Review).
reftext: TAKASHI TAKEDA, et al. Oncol Rep. 2016 Feb;35(2):607-613.
pmc_ranked_result_index: '70600'
pathway_score: 0.9383261
filename: OR-35-02-0607-g01.jpg
figtitle: ARID1A mutation and anticancer agents on the PI3K/AKT pathway
year: '2016'
organisms: Homo sapiens
ndex: ecddbf1e-df04-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4689482__OR-35-02-0607-g01.html
  '@type': Dataset
  description: Effects of ARID1A mutation and anticancer agents on the PI3K/AKT pathway.
    ARID1A mutations frequently co-occur with mutations of PTEN and PIK3CA. PTEN mutation
    inactivates PTEN and PIK3CA mutation activates PI3K, which lead to stimulation
    of cell growth, proliferation and survival. Temsirolimus inhibits the PI3K/AKT/mTOR
    signaling pathway by binding to the mTORC1 complex (). Sorafenib is a multikinase
    inhibitor that targets the mitogen-activated protein kinase (MAPK) pathway, and
    also inhibits vascular endothelial growth factor receptor (VEGFR) and platelet-derived
    growth factor receptor (PDGFR).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ARID1A
  - MTOR
  - AKT2
  - MAP2K2
  - PIK3R4
  - PDGFRB
  - PIK3R5
  - KRAS
  - PIK3CG
  - PIK3CA
  - PIK3R6
  - AKT1
  - MAP2K1
  - FLT4
  - PIK3CB
  - BRAF
  - MAPK8
  - MAPK14
  - KDR
  - MAPK3
  - PTEN
  - MAPK9
  - MAPK1
  - AKT3
  - PDGFRA
  - FLT1
  - PIK3CD
  - MAPK11
  - PIK3R3
  - MAPK13
  - MAPK12
  - MAPK10
  - Temsirolimus
  - Cancer
  - Lung cancer
genes:
- word: ARID1A
  symbol: ARID1A
  source: hgnc_symbol
  hgnc_symbol: ARID1A
  entrez: '8289'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PDGFR)
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRB
  entrez: '5159'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: (VEGFR,
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: (VEGFR,
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: PDGFR)
  symbol: PDGFR
  source: bioentities_symbol
  hgnc_symbol: PDGFRA
  entrez: '5156'
- word: (VEGFR,
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: MAPK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
chemicals:
- word: Temsirolimus
  source: MESH
  identifier: C401859
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
figid_alias: PMC4689482__F2
redirect_from: /figures/PMC4689482__F2
figtype: Figure
---
